Johnson Lloyd Emerson — SEC insider filings
SEC reporting owner CIK 1708823. 52 insider filings on record with FilingPulse; latest filed 2026-10-20.
Transaction summary — filings shown
Covers the 50 most recent of 52 filings on record, filed 2021-04-01 to 2026-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 3 filings — 71,600 shares, $1,509,294 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 24,000 shares, $1,515,120 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: sale of 24,000 shares @ $63.13 ($1,515,120) in APOGEE ENTERPRISES, INC., filed 2024-05-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| APOGEE ENTERPRISES, INC. (APOG) | Director | 30 | 2 legs · 26,600 sh · $498,679 | 1 leg · 24,000 sh · $1,515,120 | 31 |
| BEAZER HOMES USA INC (BZH) | Director | 9 | 2 legs · 45,000 sh · $1,010,614 | — | 9 |
| HAEMONETICS CORP (HAE) | Director | 6 | — | — | 6 |
| VSE CORP (VSEC) | Director | 5 | — | — | 5 |
Insider filings — Johnson Lloyd Emerson
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-20 | 4 | BEAZER HOMES USA INC (BZH) | Disposition to issuer (D): 34,630 · Disposition to issuer (D): 45,000 · Disposition to issuer (D): 7,199 | EDGAR |
| 2026-07-28 | 4 | HAEMONETICS CORP (HAE) | Grant/award (A): 2,538 | EDGAR |
| 2026-04-01 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 153 (derivative) @ $33.54 | EDGAR |
| 2026-01-06 | 4 | VSE CORP (VSEC) | Grant/award (A): 745 @ $0 | EDGAR |
| 2026-01-06 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Option exercise (M): 2,883 · Option exercise (M): 2,883 (derivative) | EDGAR |
| 2026-01-05 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 0 (derivative) @ $36.41 | EDGAR |
| 2025-11-18 | 4 | BEAZER HOMES USA INC (BZH) | Grant/award (A): 7,199 @ $0 | EDGAR |
| 2025-10-02 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 129 (derivative) @ $43.57 | EDGAR |
| 2025-07-25 | 4 | HAEMONETICS CORP (HAE) | Grant/award (A): 2,693 | EDGAR |
| 2025-07-02 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 118 (derivative) @ $40.60 | EDGAR |
| 2025-06-27 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 2,954 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 105 (derivative) @ $46.33 | EDGAR |
| 2025-02-26 | 4/A | APOGEE ENTERPRISES, INC. (APOG) | Option exercise (M): 2,811 · Grant/award (A): 75 (derivative) @ $71.41 · Option exercise (M): 2,811 (derivative) | EDGAR |
| 2025-02-11 | 4 | BEAZER HOMES USA INC (BZH) | Purchase (P): 22,500 @ $22.23 | EDGAR |
| 2025-02-10 | 4 | BEAZER HOMES USA INC (BZH) | Purchase (P): 22,500 @ $22.68 | EDGAR |
| 2025-01-06 | 4 | VSE CORP (VSEC) | Grant/award (A): 1,454 @ $0 | EDGAR |
| 2025-01-03 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 0 (derivative) @ $71.41 | EDGAR |
| 2024-11-19 | 4 | BEAZER HOMES USA INC (BZH) | Grant/award (A): 5,051 @ $0 | EDGAR |
| 2024-10-02 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 0 (derivative) @ $70.02 | EDGAR |
| 2024-07-26 | 4 | HAEMONETICS CORP (HAE) | Grant/award (A): 2,207 | EDGAR |
| 2024-07-01 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 0 (derivative) @ $62.84 | EDGAR |
| 2024-06-21 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 1,893 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4/A | APOGEE ENTERPRISES, INC. (APOG) | Purchase (P): 24,000 @ $18.75 · Purchase (P): 2,600 @ $18.73 | EDGAR |
| 2024-05-06 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Sale (S): 24,000 @ $63.13 | EDGAR |
| 2024-04-01 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 81 (derivative) @ $59.20 | EDGAR |
| 2024-01-04 | 4 | VSE CORP (VSEC) | Grant/award (A): 1,737 @ $0 | EDGAR |
| 2024-01-03 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 83 (derivative) @ $53.41 | EDGAR |
| 2023-11-21 | 4 | BEAZER HOMES USA INC (BZH) | Grant/award (A): 6,024 @ $0 | EDGAR |
| 2023-10-03 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 98 (derivative) @ $47.08 | EDGAR |
| 2023-08-08 | 4 | HAEMONETICS CORP (HAE) | Grant/award (A): 2,226 | EDGAR |
| 2023-07-05 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 83 (derivative) @ $47.47 | EDGAR |
| 2023-06-22 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 2,409 (derivative) @ $0 | EDGAR |
| 2023-04-03 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 91 (derivative) @ $43.25 | EDGAR |
| 2023-01-04 | 4 | VSE CORP (VSEC) | Grant/award (A): 2,146 @ $0 | EDGAR |
| 2023-01-04 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 81 (derivative) @ $44.46 | EDGAR |
| 2022-11-16 | 4 | BEAZER HOMES USA INC (BZH) | Grant/award (A): 14,181 @ $0 | EDGAR |
| 2022-10-04 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 93 (derivative) @ $38.22 | EDGAR |
| 2022-08-08 | 4 | HAEMONETICS CORP (HAE) | Grant/award (A): 2,730 | EDGAR |
| 2022-07-28 | 4 | VSE CORP (VSEC) | Grant/award (A): 1,369 @ $0 | EDGAR |
| 2022-07-05 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 74 (derivative) @ $39.22 | EDGAR |
| 2022-06-24 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 2,773 (derivative) @ $0 | EDGAR |
| 2022-04-04 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 62 (derivative) @ $47.46 | EDGAR |
| 2022-01-04 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 55 (derivative) @ $48.15 | EDGAR |
| 2021-11-16 | 4 | BEAZER HOMES USA INC (BZH) | Grant/award (A): 7,679 @ $0 | EDGAR |
| 2021-10-04 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 68 (derivative) @ $37.76 | EDGAR |
| 2021-08-09 | 4 | HAEMONETICS CORP (HAE) | Grant/award (A): 3,077 | EDGAR |
| 2021-07-01 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 51 (derivative) @ $40.73 | EDGAR |
| 2021-06-29 | 4 | BEAZER HOMES USA INC (BZH) | Grant/award (A): 1,695 @ $0 | EDGAR |
| 2021-06-25 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 2,721 (derivative) @ $0 | EDGAR |
| 2021-04-01 | 4 | APOGEE ENTERPRISES, INC. (APOG) | Grant/award (A): 50 (derivative) @ $40.88 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1708823 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs